Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Burosumab for Treating X-linked Hypophosphataemia in Children and Young People

  • First published: 16 September 2019
  • Last modified: 16 September 2019

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Belfast Health & Social Care Trust
Authority ID:
AA27780
Publication date:
16 September 2019
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Burosumab for treating X-linked hypophosphataemia in children and young people.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

Belfast Health and Social Care Trust

Dorothy Gardiner Unit, Knockbracken Healthcare Park

Belfast

BT8 8BH

UK

Contact person: Norma Moore

Telephone: +44 2895045210

E-mail: norma.moore@belfasttrust.hscni.net

NUTS: UKN0

Internet address(es)

Main address: http://www.belfasttrust.hscni.net

Address of the buyer profile: https://etendersni.gov.uk/epps/home.do

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Burosumab for Treating X-linked Hypophosphataemia in Children and Young People

Reference number: DACPM2019-34

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Burosumab for treating X-linked hypophosphataemia in children and young people.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 500 000.00  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UKN0

II.2.4) Description of the procurement

Burosumab for treating X-linked hypophosphataemia in children and young people.

II.2.5) Award criteria

Price

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The works, supplies or services can be provided only by a particular economic operator for the following reason: protection of exclusive rights, including intellectual property rights

Explanation

Burosumab is a branded patent protected medicines that is available from only from manufacturer Kyowa Kirin Ltd via their distributors Alcura UK Ltd.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section V: Award of contract

Contract No: DACPM2019-34

Title: Burosumab for Treating X-linked Hypophosphataemia in Children and Young People

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

10/09/2019

V.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Acura UK Ltd

Mill Lane, Unit 6 Grovepark

Alton

GU34 2QG

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 500 000.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

Belfast Health and Social Care Trust

Dorothy Gardiner Unit, Knockbracken Healthcare Park

Belfast

BT8 8BH

UK

Telephone: +44 2895045210

E-mail: norma.moore@belfasttrust.hscni.net

Internet address(es)

URL: http://www.belfasttrust.hscni.net

VI.5) Date of dispatch of this notice

12/09/2019

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
norma.moore@belfasttrust.hscni.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.